EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Clinical and Laboratory Factors Associated with Exchange Transfusion in Neonates with Severe Hyperbilirubinaemia: A Retrospective Cohort Study

Aslıhan İzol iD, Selçuk Yazıcı iD, Sümeyya Ercan

Journal of Clinical Medicine · 09.11.2026 · 15 (21) · 8762

DOI: 10.3390/jcm15218762 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 09.11.2026. Verfasst von Aslıhan İzol und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Şanlıurfa Education and Research Hospital, 63200 Şanlıurfa, Türkiye. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Exchange transfusion (ET) remains a critical intervention for severe neonatal hyperbilirubinaemia, yet laboratory associations with ET receipt require careful interpretation. We examined characteristics associated with ET and post-procedure laboratory changes. Materials and Methods: This retrospective tertiary-centre cohort included 98 neonates evaluated between January 2020 and December 2025 (65 received ET; 33 did not). A four-covariate logistic regression model assessed associations with ET receipt. Discrimination, bootstrap optimism, cross-validated calibration and an exploratory creatinine-containing model were examined.

Results

Peak total serum bilirubin (TSB) was higher among ET recipients than non-recipients (33.69 ± 6.31 versus 26.19 ± 3.64 mg/dL; p < 0.001). In the primary model (n = 98), peak TSB was associated with ET receipt (adjusted odds ratio 1.31 per mg/dL, 95% confidence interval 1.16–1.48; p < 0.001). The apparent area under the receiver operating characteristic curve (AUC) was 0.860, decreasing to 0.837 after bootstrap optimism correction. An exploratory six-covariate model (n = 97) yielded an apparent AUC of 0.874 and an optimism-corrected AUC of 0.836. Creatinine showed an adjusted association (odds ratio 1.58 per 0.1 mg/dL, 95% confidence interval 1.07–2.32), but its incremental AUC was uncertain (difference 0.014, 95% confidence interval −0.022 to 0.053). Following ET, bilirubin, platelet count and total calcium decreased.

Conclusions

Peak TSB strongly distinguished infants who received ET, but this association partly reflects the bilirubin-based indication for treatment. Creatinine did not demonstrate a reliable incremental discrimination benefit. These findings reinforce guideline-based ET assessment and post-exchange monitoring, not the adoption of new treatment thresholds or prediction tools.

Schlagwörter

Stichwörter der Autor:innen

exchange transfusionmodel validationneonatal hyperbilirubinaemiaretrospective cohorttotal serum bilirubintreatment-indication bias

Autor:innen und Institutionen

  • Department of Paediatrics, Şanlıurfa Education and Research Hospital, 63200 Şanlıurfa, Türkiye.
  • Department of Paediatrics, Private Hospital, Osmangazi Cad. No:34 Sarigazi, Sancaktepe, 34885 İstanbul, Türkiye.

ORCID-Profile: Aslıhan İzol, Selçuk Yazıcı

Zitieren

APA

İzol, A., Yazıcı, S., & Ercan, S. (2026). Clinical and Laboratory Factors Associated with Exchange Transfusion in Neonates with Severe Hyperbilirubinaemia: A Retrospective Cohort Study. Journal of Clinical Medicine, 15(21), 8762. https://doi.org/10.3390/jcm15218762

Vancouver

İzol A, Yazıcı S, Ercan S. Clinical and Laboratory Factors Associated with Exchange Transfusion in Neonates with Severe Hyperbilirubinaemia: A Retrospective Cohort Study. Journal of Clinical Medicine. 2026;15(21):8762. doi:10.3390/jcm15218762

BibTeX
@article{zol2026,
  author = {İzol, Aslıhan and Yazıcı, Selçuk and Ercan, Sümeyya},
  title = {Clinical and Laboratory Factors Associated with Exchange Transfusion in Neonates with Severe Hyperbilirubinaemia: A Retrospective Cohort Study},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {21},
  pages = {8762},
  doi = {10.3390/jcm15218762}
}
Kostenlos starten →